Physician profile
Robert K Law
NPI 1457317489
$1,416.36
in general payments reported to CMS, 2019-2025
18 companies · $72.99 in 2025
The $72.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $159 · 2021: $332 · 2022: $159 · 2024: $399 · 2025: $72.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $307 · Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $307.39 |
| Food and Beverage | $164.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $398.89 | 2024 | Venaseal |
| Janssen Pharmaceuticals, INC | $156.36 | 2020-2021 | |
| Glaxosmithkline, LLC. | $145.24 | 2019-2022 | |
| Biotronik INC. | $140.76 | 2020-2025 | Biomonitor |
| Amgen INC. | $91.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $71.60 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.32 | 2022-2025 | |
| Pfizer INC. | $63.65 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $43.45 | 2019-2021 | |
| Abbott Laboratories | $41.73 | 2021-2022 | |
| Sanofi Pasteur INC. | $38.07 | 2019-2021 | |
| Global Blood Therapeutics, INC. | $33.87 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.76 | 2019 | |
| Daiichi Sankyo INC. | $21.92 | 2022 | |
| Allergan, INC. | $20.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.00 | 2021 | |
| Merck Sharp & Dohme LLC | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.